- Home
- SXC vs IMTX Comparison
SXC vs IMTX Comparison
Compare SXC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXC
- IMTX
- Stock Information
- Founded
- SXC 1960
- IMTX N/A
- Country
- SXC United States
- IMTX Germany
- Employees
- SXC N/A
- IMTX N/A
- Industry
- SXC Steel/Iron Ore
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SXC Industrials
- IMTX Health Care
- Exchange
- SXC Nasdaq
- IMTX Nasdaq
- Market Cap
- SXC 725.5M
- IMTX 653.9M
- IPO Year
- SXC N/A
- IMTX N/A
- Fundamental
- Price
- SXC $8.39
- IMTX $5.93
- Analyst Decision
- SXC Strong Buy
- IMTX Strong Buy
- Analyst Count
- SXC 1
- IMTX 4
- Target Price
- SXC $13.00
- IMTX $14.67
- AVG Volume (30 Days)
- SXC 1.2M
- IMTX 734.9K
- Earning Date
- SXC 07-30-2025
- IMTX 08-12-2025
- Dividend Yield
- SXC 5.73%
- IMTX N/A
- EPS Growth
- SXC 51.30
- IMTX N/A
- EPS
- SXC 1.09
- IMTX N/A
- Revenue
- SXC $1,883,000,000.00
- IMTX $155,801,989.00
- Revenue This Year
- SXC N/A
- IMTX N/A
- Revenue Next Year
- SXC $0.99
- IMTX $1.92
- P/E Ratio
- SXC $7.69
- IMTX N/A
- Revenue Growth
- SXC N/A
- IMTX 93.56
- 52 Week Low
- SXC $7.47
- IMTX $3.30
- 52 Week High
- SXC $12.82
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- SXC 51.08
- IMTX 55.46
- Support Level
- SXC $8.27
- IMTX $5.50
- Resistance Level
- SXC $8.99
- IMTX $5.82
- Average True Range (ATR)
- SXC 0.25
- IMTX 0.27
- MACD
- SXC 0.06
- IMTX -0.03
- Stochastic Oscillator
- SXC 56.82
- IMTX 50.49
About SXC SunCoke Energy Inc.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is primarily used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through three segments: Domestic Coke, Brazil Coke, and Logistics. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.